The precision of both IGFBP7 and TIMP-2 with regard to predicting AKI occurrence is greater in comparison to Cystatin C, KIM-1, L-FABP, NGAL, and IL-18 [55,56]. This evidence concerns the gene FABP1 and acute kidney injury.